Risk factors for unplanned discontinuation of scheduled treatment in elderly patients with castration-resistant prostate cancer: results of the IBuTu study.
Friedemann HoneckerUlrich WeddingGerd KallischniggAxel SchroederJörg KlierThomas FrangenheimLothar WeißbachPublished in: Journal of cancer research and clinical oncology (2018)
Despite limitations due to early termination of the study, our results demonstrate that discontinuation of scheduled treatment was common, and that compromised ADL seems to be a significant risk factor for treatment failure in elderly patients with CRPC.
Keyphrases